Literature DB >> 6821130

alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.

C E Weeks, A L Herrmann, F R Nelson, T J Slaga.   

Abstract

The role of ornithine decarboxylase (OrnDCase, EC 4.1.1.17) and of the polyamines [putrescine (Put), spermidine (Spd), and spermine (Spm)] in mouse skin tumor promotion was investigated by the use of alpha-difluoromethylornithine (CHF2-Orn), an enzyme-activated irreversible inhibitor of OrnDCase. 12-O-Tetradecanoylphorbol 13-acetate (TPA), mezerein, and ethyl phenylpropiolate (EPP) were employed as complete, stage II specific, and nonpromoting agents, respectively. TPA and mezerein, but not EPP, provided for a dose-dependent increase in tissue Put accumulation. The Put level in papillomas developed by TPA (2 micrograms) treatment was approximately equal to 15-fold higher than that of the surrounding skin tissue; Spd accumulation was 2- to 3-fold greater in the papillomas. Put administered (intraperitoneally) with TPA greatly enhanced papilloma yield. CHF2-Orn, given orally or intraperitoneally, abolished the TPA-induced OrnDCase activity and Put accumulation in mouse epidermis. The reduction of polyamine accumulation by CHF2-Orn was directly proportional to reduction of tumor size. CHF2-Orn administered in a two-stage (TPA-mezerein) promotion protocol [Slaga, T. J., Fischer, S. M., Nelson, K. G. & Gleason, G. L. (1980) Proc. Natl. Acad. Sci. USA 77, 3659-3663; Slaga, T. J., Klein-Szanto, A. J. P., Fischer, S. M., Weeks, C. E., Nelson, K. & Major, S. (1980) Proc. Natl. Acad. Sci. USA 77, 2251-2254] reduced tumor size, inhibited by 65-70% the number of papillomas per mouse, and decreased by 40% the percentage of mice with tumors when given with the stage II agent mezerein. CHF2-Orn provided considerably less effect on tumorigenesis when administered with the TPA portion of the protocol, and CHF2-Orn did not inhibit the induction of dark basal keratinocytes by TPA. Based on our results with CHF2-Orn, we suggest that regulation of polyamine biosynthesis, particularly Put, is a critical factor in stage II promotion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6821130      PMCID: PMC347045          DOI: 10.1073/pnas.79.19.6028

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Inhibition of phorbol ester-induced polyamine accumulation in mouse epidermis by anti-inflammatory steroid.

Authors:  C E Weeks; T J Slaga
Journal:  Biochem Biophys Res Commun       Date:  1979-12-28       Impact factor: 3.575

2.  Inhibition of EMT6 tumor growth by interference with polyamine biosynthesis; effects of alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase.

Authors:  N J Prakash; P J Schechter; P S Mamont; J Grove; J Koch-Weser; A Sjoerdsma
Journal:  Life Sci       Date:  1980-01-21       Impact factor: 5.037

3.  Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  A K Verma; C L Ashendel; R K Boutwell
Journal:  Cancer Res       Date:  1980-02       Impact factor: 12.701

4.  Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3':5'-monophosphate, and induction of mouse skin tumors in vivo.

Authors:  R A Mufson; S M Fischer; A K Verma; G L Gleason; T J Slaga; R K Boutwell
Journal:  Cancer Res       Date:  1979-12       Impact factor: 12.701

5.  Polyamine and differentiation: induction of ornithine decarboxylase by parathyroid hormone is a good marker of differentiated chondrocytes.

Authors:  M Takigawa; H Ishida; T Takano; F Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

6.  Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion.

Authors:  T J Slaga; A J Klein-Szanto; S M Fischer; C E Weeks; K Nelson; S Major
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

7.  L-Ornithine decarboxylase:an essential role in early mammalian embryogenesis.

Authors:  J R Fozard; M L Part; N J Prakash; J Grove; P J Schechter; A Sjoerdsma; J Koch-Weser
Journal:  Science       Date:  1980-05-02       Impact factor: 47.728

8.  Polyamine biosynthesis enzymes in the induction and inhibition of differentiation in Friend erythroleukemia cells.

Authors:  Y Gazitt; C Friend
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

9.  Ornithine decarboxylase is important in intestinal mucosal maturation and recovery from injury in rats.

Authors:  G D Lux; L J Marton; S B Baylin
Journal:  Science       Date:  1980-10-10       Impact factor: 47.728

10.  Polyamine metabolism: a potential therapeutic target in trypanosomes.

Authors:  C J Bacchi; H C Nathan; S H Hutner; P P McCann; A Sjoerdsma
Journal:  Science       Date:  1980-10-17       Impact factor: 47.728

View more
  20 in total

Review 1.  Polyamines and cancer: implications for chemotherapy and chemoprevention.

Authors:  Shannon L Nowotarski; Patrick M Woster; Robert A Casero
Journal:  Expert Rev Mol Med       Date:  2013-02-22       Impact factor: 5.600

Review 2.  The chemotherapeutic potential of polyamine antimetabolites.

Authors:  A N Kingsnorth
Journal:  Ann R Coll Surg Engl       Date:  1986-03       Impact factor: 1.891

3.  Active oxygen acts as a promoter of transformation in mouse embryo C3H/10T1/2/C18 fibroblasts.

Authors:  R Zimmerman; P Cerutti
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  Effects of alpha-difluromethylornithine on the development of deeply invasive urinary bladder carcinomas in mice.

Authors:  S Samma; K Uchida; J Seidenfeld; R Oyasu
Journal:  Urol Res       Date:  1990

Review 5.  Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer.

Authors:  Eugene W Gerner; Elizabeth Bruckheimer; Alfred Cohen
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

6.  Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administration.

Authors:  A M Maddox; E J Freireich; M J Keating; K F Frasier-Scott; M K Haddox
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

Review 7.  A perspective of polyamine metabolism.

Authors:  Heather M Wallace; Alison V Fraser; Alun Hughes
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

8.  Ornithine decarboxylase from mouse epidermis and epidermal papillomas: differences in enzymatic properties and structure.

Authors:  T G O'Brien; T Madara; J A Pyle; M Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  Role of protein kinase C in diacylglycerol-mediated induction of ornithine decarboxylase and reduction of epidermal growth factor binding.

Authors:  A M Jetten; B R Ganong; G R Vandenbark; J E Shirley; R M Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

10.  Focal smooth muscle proliferation in the aortic intima produced by an initiation-promotion sequence.

Authors:  M W Majesky; M A Reidy; E P Benditt; M R Juchau
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.